Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

ClinicalTrials.gov ID: NCT02682264

Public ClinicalTrials.gov record NCT02682264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 7:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the long-term safety of CB-03-01 cream, 1% applied twice daily for an additional nine months in study participants with acne vulgaris that participated in the Phase 3 pivotal studies for a total treatment of up to 12 months.

Study identification

NCT ID
NCT02682264
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cassiopea SpA
Industry
Enrollment
609 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 9, 2016 (Actual)
Primary completion
Aug 31, 2018 (Actual)
Completion
Aug 31, 2018 (Actual)
Last update posted
Nov 17, 2020

2016 – 2018

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Johnson Dermatology Fort Smith Arkansas 72916 —
Gary M. Petrus, MD PA Little Rock Arkansas 72205 —
Center for Dermatology and Laser Surgery Sacramento California 95819 —
Rady Childrens Hospital, Pediatric and Adolescent Dermatology San Diego California 92123 —
Southern California Dermatology Santa Ana California 92701 —
Clinical Science Institute Santa Monica California 90404 —
Memorial Research Medical Clinic dba / Orange County Research Center Tustin California 92780 —
Horizons Clinical Research Center, LLC Denver Colorado 80220 —
Study Protocol, Inc. Boynton Beach Florida 33437 —
Tory Sullivan, M.D., P.A. North Miami Beach Florida 33162 —
Belleair Research Center Pinellas Park Florida 33781 —
Meridien Research St. Petersburg Florida 33709 —
MOORE Clinical Research, Inc. Tampa Florida 33609 —
MedaPhase, Inc. Newnan Georgia 30263 —
Arlington Dermatology Arlington Heights Illinois 60005 —
Shideler Clinical Research Center Carmel Indiana 46032 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
Kansas City Dermatology, PA Overland Park Kansas 66215 —
Maryland Laser Skin and Vein Institute Hunt Valley Maryland 21030 —
Henry Ford Health System Detroit Michigan 48202 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Sadick Research Group, LLC New York New York 10075 —
Skin Specialty Dermatology New York New York 10155 —
DermResearch Center of New York, Inc. Stony Brook New York 11790 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
The Pennsylvania State University and the Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
Omega Medical Research Warwick Rhode Island 02886 —
Greenville Dermatology, LLC Greenville South Carolina 29607 —
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
Westlake Dermatology Clinical Research Center Austin Texas 78746 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Progressive Clinical Research, PA San Antonio Texas 78229 —
Clinical Research Associates of Tidewater, Inc. Norfolk Virginia 23507 —
Dermatology Associates Seattle Washington 98101 —
Premier Clinical Research Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02682264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2020 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02682264 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →